Anti-inflammatory effects of freeze-dried black raspberry powder in ulcerative colitis

Carcinogenesis

Volumn 32, Issue 3, 2011, Pages 343-350

  Montrose, David C ^a   Horelik, Nicole A ^a   Madigan, James P ^a   Stoner, Gary D ^b   Wang, Li Shu ^b   Bruno, Richard S ^c   Park, Hea Jin ^c   Giardina, Charles ^c   Rosenberg, Daniel W ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; DEXTRAN SULFATE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MALONALDEHYDE; NITRIC OXIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BODY MASS; CELL INFILTRATION; COLON; COLON DISEASE; COLON MUCOSA; COLON SHORTENING; COLON ULCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET THERAPY; DISEASE SEVERITY; DRY POWDER; ENZYME REPRESSION; FREEZE DRIED BLACK RASPBERRY; FREEZE DRYING; INFLAMMATORY CELL; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROTEIN SYNTHESIS INHIBITION; RASPBERRY; THERAPY EFFECT; TISSUE LEVEL; TRANSCRIPTION REGULATION; ULCERATIVE COLITIS; WESTERN BLOTTING;

EID: 79952285549     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq248     Document Type: Article

References (50)

1. Xu, C.T. et al. (2004) Drug therapy for ulcerative colitis. World J. Gastroenterol., 10, 2311-2317.
2. Seril, D.N. et al. (2003) Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis, 24, 353-362.
3. Sharon, P. et al. (1978) Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology, 75, 638-640.
4. Stenson, W.F. (1990) Role of eicosanoids as mediators of inflammation in inflammatory bowel disease. Scand. J. Gastroenterol., 172 (suppl.), 13-18.
5. Rubin, D.T. et al. (2006) Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis. Clin. Gastroenterol. Hepatol., 4, 1346-1350.
6. Velayos, F.S. et al. (2005) Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am. J. Gastroenterol., 100, 1345-1353.
7. Zafra-Stone, S. et al. (2007) Berry anthocyanins as novel antioxidants in human health and disease prevention. Mol. Nutr. Food Res., 51, 675-683.
8. Daniel, E. (1989) Extraction, stability, and quantitation of ellagic acid in various fruits and nuts. J. Food Comp. Anal., 2, 338-349.
9. Wada, L. et al. (2002) Antioxidant activity and phenolic content of Oregon caneberries. J. Agric. Food Chem., 50, 3495-3500.
10. Afaq, F. et al. (2005) Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice. Int. J. Cancer, 113, 423-433.
11. Reddy, M.K. et al. (2005) Relative inhibition of lipid peroxidation, cyclo-oxygenase enzymes, and human tumor cell proliferation by natural food colors. J. Agric. Food Chem., 53, 9268-9273.
12. Rodrigo, K.A. et al. (2006) Suppression of the tumorigenic phenotype in human oral squamous cell carcinoma cells by an ethanol extract derived from freeze-dried black raspberries. Nutr. Cancer, 54, 58-68.
13. Olsson, M.E. et al. (2004) Inhibition of cancer cell proliferation in vitro by fruit and berry extracts and correlations with antioxidant levels. J. Agric. Food Chem., 52, 7264-7271.
14. Parry, J. et al. (2006) Chemical compositions, antioxidant capacities, and antiproliferative activities of selected fruit seed flours. J. Agric. Food Chem., 54, 3773-3778.
15. Renis, M. et al. (2008) Response of cell cycle/stress-related protein expression and DNA damage upon treatment of CaCo2 cells with anthocyanins. Br. J. Nutr., 100, 27-35.
16. Shih, P.H. et al. (2007) Anthocyanins induce the activation of phase II enzymes through the antioxidant response element pathway against oxidative stress-induced apoptosis. J. Agric. Food Chem., 55, 9427-9435.
17. Wang, S.Y. et al. (2000) Scavenging capacity of berry crops on superoxide radicals, hydrogen peroxide, hydroxyl radicals, and singlet oxygen. J. Agric. Food Chem., 48, 5677-5684.
18. Kresty, L.A. et al. (2001) Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res., 61, 6112-6119.
19. Stoner, G.D. et al. (2008) Carcinogen-altered genes in rat esophagus positively modulated to normal levels of expression by both black raspberries and phenylethyl isothiocyanate. Cancer Res., 68, 6460-6467.
20. Wang, L.S. et al. (2009) Anthocyanins in black raspberries prevent esophageal tumors in rats. Cancer Prev. Res., (Phila), 2, 84-93.
21. Casto, B.C. et al. (2002) Chemoprevention of oral cancer by black raspberries. Anticancer Res., 22, 4005-4015.
22. Duncan, F.J. et al. (2009) Topical treatment with black raspberry extract reduces cutaneous UVB-induced carcinogenesis and inflammation. Cancer Prev. Res. (Phila), 2, 665-672.
23. Harris, G.K. et al. (2001) Effects of lyophilized black raspberries on azoxymethane-induced colon cancer and 8-hydroxy-2'-deoxyguanosine levels in the Fischer 344 rat. Nutr. Cancer, 40, 125-133.
24. Kang, S.Y. et al. (2003) Tart cherry anthocyanins inhibit tumor development in Apc(Min) mice and reduce proliferation of human colon cancer cells. Cancer Lett., 194, 13-19.
25. Chen, T. et al. (2006) Chemopreventive properties of black raspberries in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis: down-regulation of cyclooxygenase-2, inducible nitric oxide synthase, and c-Jun. Cancer Res., 66, 2853-2859.
26. Chen, T. et al. (2006) Black raspberries inhibit N-nitrosomethylbenzylamine (NMBA)-induced angiogenesis in rat esophagus parallel to the suppression of COX-2 and iNOS. Carcinogenesis, 27, 2301-2307.
27. Stoner, G.D. (2009) Foodstuffs for preventing cancer: the preclinical and clinical development of berries. Cancer Prev. Res. (Phila), 2, 187-194.
28. Young, I.S. et al. (1991) Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann. Clin. Biochem., 28, (Pt 5), 504-508.
29. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
30. Bhattacharyya, S. et al. (2009) ROS, Hsp27, and IKKbeta mediate dextran sodium sulfate (DSS) activation of IkappaBa, NFkappaB, and IL-8. Inflamm. Bowel Dis., 15, 673-683.
31. Oz, H.S. et al. (2005) Antioxidants as novel therapy in a murine model of colitis. J. Nutr. Biochem., 16, 297-304.
32. You, Y. et al. (2009) Effect of N-acetylcysteine on the murine model of colitis induced by dextran sodium sulfate through up-regulating PON1 activity. Dig. Dis. Sci., 54, 1643-1650.
33. Huang, C. et al. (2002) Inhibition of benzo(a)pyrene diol-epoxide-induced transactivation of activated protein 1 and nuclear factor kappaB by black raspberry extracts. Cancer Res., 62, 6857-6863.
34. Scher, J.U. et al. (2009) The anti-inflammatory effects of prostaglandins. J. Investig. Med., 57, 703-708.
35. Stoner, G.D. et al. (2007) Cancer prevention with freeze-dried berries and berry components. Semin. Cancer Biol., 17, 403-410.
36. Amini-Shirazi, N. et al. (2009) Inhibition of tumor necrosis factor and nitrosative/oxidative stresses by Ziziphora clinopoides (Kahlioti); a molecular mechanism of protection against dextran sodium sulfate-induced colitis in mice. Toxicol. Mech. Methods, 19, 183-189.
37. Wang, L.S. et al. (2008) Anthocyanins and their role in cancer prevention. Cancer Lett., 269, 281-290.
38. Li, J. et al. (2008) Differential effects of black raspberry and strawberry extracts on BaPDE-induced activation of transcription factors and their target genes. Mol. Carcinog., 47, 286-294.
39. Karin, M. (1999) The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J. Biol. Chem., 274, 27339-27342.
40. Mercurio, F. et al. (1997) IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science, 278, 860-866.
41. Woronicz, J.D. et al. (1997) IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science, 278, 866-869.
42. Brown, K. et al. (1993) Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc. Natl Acad. Sci. USA, 90, 2532-2536.
43. Sun, S.C. et al. (1993) NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science, 259, 1912-1915.
44. Crofford, L.J. et al. (1997) Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum., 40, 226-236.
45. Plummer, S.M. et al. (1999) Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene, 18, 6013-6020.
46. Schmedtje, J.F. Jr. et al. (1997) Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem., 272, 601-608.
47. Greten, F.R. et al. (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell, 118, 285-296.
48. Carlton, P.S. et al. (2002) Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus. Cancer Res., 62, 4376-4382.
49. Melgar, S. et al. (2006) Local production of chemokines and prostaglandin E2 in the acute, chronic and recovery phase of murine experimental colitis. Cytokine, 35, 275-283.
50. Zijlstra, F.J. et al. (1992) Experimental colitis in mice: effects of olsalazine on eicosanoid production in colonic tissue. Agents Actions, C76-C78.